Varian gets US nod for brachytherapy planning software:
This article was originally published in Clinica
Varian Medical Systems has received US FDA 510(k) clearance for an improved and faster version of its VariSeed treatment planning software for permanent seed implant brachytherapy in prostate cancer patients. VariSeed 7.1 incorporates an optional feature, called Twister. The longitudinal volume acquisition module enables doctors to use ultrasound images of the prostate that have been taken without repositioning the probe, a process that can disturb or distort the prostate and yield inaccurate images, says the Palo Alto, California firm.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.